Paricalcitol for prevention and reduction of albuminuria in renal transplant patients

Trial Profile

Paricalcitol for prevention and reduction of albuminuria in renal transplant patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2015

At a glance

  • Drugs Paricalcitol (Primary)
  • Indications Proteinuria
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Nov 2015 New trial record
    • 16 Sep 2015 Results presented at 17th Congress of the European Society for Organ Transplantation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top